-
3-{[(3S)-1-[2-(3,4-dimethoxyphenyl)ethyl]piperidin-3-yl]methyl}-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one hydrochloride
-
ChemBase ID:
155713
-
Molecular Formular:
C28H39ClN2O5
-
Molecular Mass:
519.07266
-
Monoisotopic Mass:
518.25475004
-
SMILES and InChIs
SMILES:
COc1ccc(cc1OC)CCN1CCC[C@@H](C1)CN1CCc2cc(c(cc2CC1=O)OC)OC.Cl
Canonical SMILES:
COc1ccc(cc1OC)CCN1CCC[C@@H](C1)CN1CCc2c(CC1=O)cc(c(c2)OC)OC.Cl
InChI:
InChI=1S/C28H38N2O5.ClH/c1-32-24-8-7-20(14-25(24)33-2)9-12-29-11-5-6-21(18-29)19-30-13-10-22-15-26(34-3)27(35-4)16-23(22)17-28(30)31;/h7-8,14-16,21H,5-6,9-13,17-19H2,1-4H3;1H/t21-;/m0./s1
InChIKey:
MTAKUIYCCYKGJJ-BOXHHOBZSA-N
-
Cite this record
CBID:155713 http://www.chembase.cn/molecule-155713.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
3-{[(3S)-1-[2-(3,4-dimethoxyphenyl)ethyl]piperidin-3-yl]methyl}-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one hydrochloride
|
|
|
|
|
IUPAC Traditional name
|
|
3-{[(3S)-1-[2-(3,4-dimethoxyphenyl)ethyl]piperidin-3-yl]methyl}-7,8-dimethoxy-4,5-dihydro-1H-3-benzazepin-2-one hydrochloride
|
|
|
|
|
Synonyms
|
|
(S)-(+)-7,8-Dimethoxy-3-[[1-(2-(3,4-dimethoxyphenyl)ethyl)-3-piperidinyl]methyl]-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride
|
|
Cilobradine hydrochloride
|
|
DK-AH 269
|
|
cilobradine 盐酸盐
|
|
|
|
|
CAS Number
|
|
|
MDL Number
|
|
|
PubChem SID
|
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
LogD (pH = 7.4)
|
1.8094167
|
Log P
|
3.202705
|
Molar Refractivity
|
137.6815 cm3
|
Polarizability
|
53.28943 Å3
|
Polar Surface Area
|
60.47 Å2
|
Rotatable Bonds
|
9
|
Lipinski's Rule of Five
|
false
|
H Acceptors
|
6
|
H Donor
|
0
|
LogD (pH = 5.5)
|
0.12753986
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
D6942
|
Biochem/physiol Actions DK-AH 269 (Cilobradine) is an HCN Channel blocker; an open channel blocker of neuronal Ih and related cardiac If channels. |
PATENTS
PATENTS
PubChem Patent
Google Patent